Human tumor-derived exosomes selectively impair lymphocyte responses to interleukin-2.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Cancer Research

• Publication date

  2007-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/0008-5472.CAN-06-3456PMID 17671216
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cutting Edge: Immature Human Dendritic Cells Express Latency-Associated Peptide and Inhibit T Cell Activation in a TGF-β-Dependent Manner1

  2007cited by this paper
• Foxp3+CD4+CD25+ T cells control virus-specific memory T cells in chimpanzees that recovered from hepatitis C.

  2006cited by this paper
• Isolation and Characterization of Exosomes from Cell Culture Supernatants and Biological Fluids

  2006cited by this paper
• IL-2 regulates FOXP3 expression in human CD4+CD25+ regulatory T cells through a STAT-dependent mechanism and induces the expansion of these cells in vivo.

  2006cited by this paper
• Murine Mammary Carcinoma Exosomes Promote Tumor Growth by Suppression of NK Cell Function1

  2006cited by this paper
• Lipopolysaccharide-Activated CD4+CD25+ T Regulatory Cells Inhibit Neutrophil Function and Promote Their Apoptosis and Death1

  2006cited by this paper
• IL-2 administration increases CD4+ CD25(hi) Foxp3+ regulatory T cells in cancer patients.

  2006cited by this paper
• Treg-mediated immunosuppression involves activation of the Notch-HES1 axis by membrane-bound TGF-β

  2006cited by this paper
• Treg-mediated immunosuppression involves activation of the Notch-HES1 axis by membrane-bound TGF-beta.

  2006cited by this paper
• Tumor exosomes expressing Fas ligand mediate CD8+ T-cell apoptosis

  2005cited by this paper
• Exosomes and the MICA-NKG2D system in cancer.

  2005cited by this paper
• Regulatory T cell lineage specification by the forkhead transcription factor foxp3.

  2005cited by this paper
• More Efficient Induction of HLA-A*0201-Restricted and Carcinoembryonic Antigen (CEA)–Specific CTL Response by Immunization with Exosomes Prepared from Heat-Stressed CEA-Positive Tumor Cells

  2005cited by this paper
• Heat shock protein 70 surface-positive tumor exosomes stimulate migratory and cytolytic activity of natural killer cells.

  2005cited by this paper
• Exosomal-like vesicles are present in human blood plasma.

  2005cited by this paper
• Induction of heat shock proteins in B-cell exosomes

  2005cited by this paper
• ICAM-1 on exosomes from mature dendritic cells is critical for efficient naive T-cell priming.

  2005cited by this paper
• Tumour-derived exosomes and their role in cancer-associated T-cell signalling defects

  2005cited by this paper
• Proteomic analysis of exosomes isolated from human malignant pleural effusions.

  2004cited by this paper
• Exosomes as Potent Cell-Free Peptide-Based Vaccine. I. Dendritic Cell-Derived Exosomes Transfer Functional MHC Class I/Peptide Complexes to Dendritic Cells 1

  2004cited by this paper
• Modified RECIST criteria for assessment of response in malignant pleural mesothelioma.

  2004cited by this paper
• TGF-β1 Plays an Important Role in the Mechanism of CD4+CD25+ Regulatory T Cell Activity in Both Humans and Mice

  2004cited by this paper
• Exosomes as Potent Cell-Free Peptide-Based Vaccine. II. Exosomes in CpG Adjuvants Efficiently Prime Naive Tc1 Lymphocytes Leading to Tumor Rejection 1

  2004cited by this paper
• Exosomes from Plasmacytoma Cells as a Tumor Vaccine

  2004cited by this paper
• Tumor exosomes expressing fas ligand mediate CD8+ T cell apoptosis

  2004cited by this paper
• TGF-beta 1 plays an important role in the mechanism of CD4+CD25+ regulatory T cell activity in both humans and mice.

  2004cited by this paper
• Direct stimulation of naïve T cells by membrane vesicles from antigen-presenting cells: Distinct roles for CD54 and B7 molecules

  2003influential reference
• Malignant effusions and immunogenic tumour-derived exosomes.

  2002influential reference
• A cautionary note on experimental artefacts induced by fetal calf serum in a viral model of pulmonary eosinophilia.

  2002cited by this paper
• A Role for NF-κB Activation in Perforin Expression of NK Cells Upon IL-2 Receptor Signaling1

  2002cited by this paper
• Production and characterization of clinical grade exosomes derived from dendritic cells.

  2002cited by this paper
• A role for NF-kappa B activation in perforin expression of NK cells upon IL-2 receptor signaling.

  2002influential reference
• Induction of Lymphocyte Apoptosis by Tumor Cell Secretion of FasL-bearing Microvesicles

  2002influential reference
• Exosomes: composition, biogenesis and function

  2002cited by this paper
• Proteomic Analysis of Dendritic Cell-Derived Exosomes: A Secreted Subcellular Compartment Distinct from Apoptotic Vesicles1

  2001cited by this paper
• Mast Cell-Dependent B and T Lymphocyte Activation Is Mediated by the Secretion of Immunologically Active Exosomes1

  2001cited by this paper
• Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming

  2001influential reference
• A novel mechanism for regulating transforming growth factor beta (TGF-beta) signaling. Functional modulation of type III TGF-beta receptor expression through interaction with the PDZ domain protein, GIPC.

  2001cited by this paper
• "Tolerosomes" are produced by intestinal epithelial cells

  2001cited by this paper
• Direct Immunosuppressive Effects of EBV-Encoded Latent Membrane Protein 1

  2000cited by this paper
• Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell derived exosomes

  1998cited by this paper
• Molecular cloning of mesothelin, a differentiation antigen present on mesothelium, mesotheliomas, and ovarian cancers.

  1996cited by this paper
• Characterization of a cell line, NKL, derived from an aggressive human natural killer cell leukemia.

  1996cited by this paper
• B lymphocytes secrete antigen-presenting vesicles

  1996cited by this paper
• Cell and tissue culture laboratory procedures

  1994cited by this paper
• Transforming growth factor-beta (TGF-beta) receptor proteoglycan. Cell surface expression and ligand binding in the absence of glycosaminoglycan chains.

  1989cited by this paper
• August 1

  1964cited by this paper
• Transforming Growth Factor-@ (TGF-@) Receptor Proteoglycan CELL SURFACE EXPRESSION AND LIGAND BINDING IN THE ABSENCE OF GLYCOSAMINOGLYCAN CHAINS*

  year unknowncited by this paper

• The immune landscape of systemic inflammation in prostate cancer

  2025cites this paper
• GC-derived exosomal circMAN1A2 promotes cancer progression and suppresses T-cell antitumour immunity by inhibiting FBXW11-mediated SFPQ degradation

  2025cites this paper
• Exercise-induced modulation of circulating and exosomal microRNAs and long non-coding RNAs: Molecular signatures in cancer diagnosis, prevention and therapy.

  2025cites this paper
• Ad-SGE-DKK3 Gene Therapy Overcomes Resistance to Immune Checkpoint Blockade in Pleural Mesothelioma.

  2025cites this paper
• Towards implementing optimized methodologies and in-depth molecular profiling to assess the pharmacological potential of human lung fibroblast exosomes as bio-shuttles for cancer therapeutics.

  2025cites this paper
• Extracellular vesicular microRNAs and cardiac hypertrophy

  2025cites this paper
• Crosstalk Between Extracellular Vesicles and Regulatory T Cells Across Cancers: From Interaction to Therapeutic Potential

  2025cites this paper
• Extracellular vesicles from Candidozyma (Candida) auris inhibit proliferation of CD4 T cells by disrupting the IL-2 axis.

  2025cites this paper
• Role of exosomes in transforming growth factor-β-mediated cancer cell plasticity and drug resistance

  2025cites this paper
• Extracellular Vesicles in Cancer Immunotherapy: Therapeutic, Challenges and Clinical Progress

  2025cites this paper
• Harnessing Exosomes: From Tumor Immune Escape to Therapeutic Innovation in Gastric Cancer Immunotherapy.

  2025cites this paper
• Proteome alterations in peripheral immune cells of DLBCL patients and evidence of cancer extracellular vesicles involvement.

  2025cites this paper
• Effect of Extracellular Vesicles Derived From Tumor Cells on Immune Evasion

  2025cites this paper
• Small Extracellular Vesicle (sEV) Uptake from Lung Adenocarcinoma and Squamous Cell Carcinoma Alters T-Cell Cytokine Expression and Modulates Protein Profiles in sEV Biogenesis

  2025cites this paper
• Emerging cell-based and cell-free therapeutic strategies for vitiligo

  2025cites this paper
• Role of tumor-derived exosomes and immune cells in osteosarcoma progression and targeted therapy

  2025cites this paper
• Harnessing the power of exosomes for diagnosis, prognosis, and treatment of hematological malignancies

  2025cites this paper
• Extracellular vesicles—a new player in the development of urinary bladder cancer

  2025cites this paper
• Cancer-derived extracellular vesicles in natural killer cell immune evasion: molecular mechanisms and therapeutic insights.

  2025cites this paper
• Extracellular vesicles in cancer´s communication: messages we can read and how to answer

  2025cites this paper
• The biological function of extracellular vesicles in prostate cancer and their clinical application as diagnostic and prognostic biomarkers

  2024cites this paper
• A comprehensive review of challenges and advances in exosome-based drug delivery systems

  2024cites this paper
• Implications of glioblastoma-derived exosomes in modifying the immune system: state-of-the-art and challenges

  2024cites this paper
• Updates on altered signaling pathways in tumor drug resistance

  2024cites this paper
• Tumor immune escape: extracellular vesicles roles and therapeutics application

  2024cites this paper
• Improving regulatory T cell-based therapy: insights into post-translational modification regulation.

  2024cites this paper
• Exosomes derived from cancer cells relieve inflammatory bowel disease in mice

  2024cites this paper
• Engineered exosomes in service of tumor immunotherapy: From optimizing tumor‐derived exosomes to delivering CRISPR/Cas9 system

  2024cites this paper
• Regulatory T cell-mediated immunosuppression orchestrated by cancer: towards an immuno-genomic paradigm for precision medicine

  2024cites this paper
• Tumor Microenvironment-Derived Exosomes: A Double-Edged Sword for Advanced T Cell-Based Immunotherapy.

  2024cites this paper
• Shaping the immune‐suppressive microenvironment on tumor‐associated myeloid cells through tumor‐derived exosomes

  2024cites this paper
• Therapeutic potential of exosomes derived from mesenchymal stem cells for treatment of systemic lupus erythematosus

  2024cites this paper
• A TRP to Pathological Angiogenesis and Vascular Normalization.

  2024cites this paper
• Harnessing extracellular vesicle-mediated crosstalk between T cells and cancer cells for therapeutic applications.

  2024cites this paper
• Extracellular Vesicles and Immunity: At the Crossroads of Cell Communication

  2024cites this paper
• Tumour-derived extracellular vesicle based vaccines for melanoma treatment

  2023cites this paper
• Effects of extracellular vesicle-derived noncoding RNAs on pre-metastatic niche and tumor progression

  2023cites this paper
• Exosomes: A potential tool for immunotherapy of ovarian cancer

  2023cites this paper
• Exosomes in Colorectal Cancer: From Physiology to Clinical Applications

  2023cites this paper
• Extracellular vesicle-based liquid biopsy biomarkers and their application in precision immuno-oncology

  2023cites this paper
• Small extracellular vesicle TGF-β in cancer progression and immune evasion

  2023influential citation
• Dual effects of radiotherapy on tumor microenvironment and its contribution towards the development of resistance to immunotherapy in gastrointestinal and thoracic cancers

  2023cites this paper
• Special Issue: Nanotherapeutics in Women's Health Emerging Nanotechnologies for Triple-Negative Breast Cancer Treatment.

  2023cites this paper
• Milk/colostrum exosomes: A nanoplatform advancing delivery of cancer therapeutics.

  2023cites this paper
• The Role of Exosomes in Human Carcinogenesis and Cancer Therapy—Recent Findings from Molecular and Clinical Research

  2023cites this paper
• Extracellular Vesicles: New Classification and Tumor Immunosuppression

  2023cites this paper
• PKC-ζ mediated reduction of the extracellular vesicles-associated TGF-β1 overcomes radiotherapy resistance in breast cancer

  2023cites this paper
• Tumor-derived nanoseeds condition the soil for metastatic organotropism.

  2023cites this paper
• Role of extracellular vesicles in osteosarcoma

  2022cites this paper
• Engineered extracellular vesicles and their mimetics for cancer immunotherapy.

  2022cites this paper
• The Potential Role of Exosomal Proteins in Prostate Cancer

  2022cites this paper
• Molecular mechanisms and clinical applications of exosomes in prostate cancer

  2022influential citation
• CHMP2A regulates tumor sensitivity to natural killer cell-mediated cytotoxicity

  2022cites this paper
• Colorectal liver metastasis: molecular mechanism and interventional therapy

  2022cites this paper
• Current advances in the use of exosomes, liposomes, and bioengineered hybrid nanovesicles in cancer detection and therapy

  2022cites this paper
• The Role of Exosomal Non-Coding RNAs in Colorectal Cancer Drug Resistance

  2022cites this paper
• Role of exosomes and its emerging therapeutic applications in the pathophysiology of non-infectious diseases

  2022cites this paper
• Immune Microenvironment in Osteosarcoma: Components, Therapeutic Strategies and Clinical Applications

  2022cites this paper
• Exosomes in cancer immunoediting and immunotherapy

  2022cites this paper
• Cancer exosomes and natural killer cells dysfunction: biological roles, clinical significance and implications for immunotherapy

  2022influential citation
• Extracellular vesicles, tumor growth, and the metastatic process

  2022cites this paper
• Tumor-derived exosomes in the cancer immune microenvironment and cancer immunotherapy.

  2022cites this paper
• Ursodeoxycholic acid reduces antitumor immunosuppression by inducing CHIP-mediated TGF-β degradation

  2022cites this paper
• Extracellular vesicles in tumor immunotherapy

  2022cites this paper
• Harnessing the Therapeutic Potential of Exosomes: A Novel Strategy for Anticancer and Antiviral Therapy

  2022cites this paper
• Extracellular Vesicles and Their Roles in the Tumor Immune Microenvironment

  2022cites this paper
• Extracellular vesicles in ovarian cancer chemoresistance, metastasis, and immune evasion

  2022cites this paper
• Tumor-Derived Extracellular Vesicles in Cancer Immunoediting and Their Potential as Oncoimmunotherapeutics

  2022cites this paper
• Tumour Derived Extracellular Vesicles: Challenging Target to Blunt Tumour Immune Evasion

  2022cites this paper
• Exosomes carrying immune checkpoints, a promising therapeutic approach in cancer treatment

  2022cites this paper
• Role of exosomes in lung cancer: A comprehensive insight from immunomodulation to theragnostic applications.

  2022cites this paper
• Trends in the biological functions and medical applications of extracellular vesicles and analogues

  2021cites this paper
• Exosomes in Liquid Biopsy: The Nanometric World in the Pursuit of Precision Oncology

  2021cites this paper
• Extracellular vesicles in urological malignancies

  2021cites this paper
• Extracellular vesicles in kidneys and their clinical potential in renal diseases

  2021cites this paper
• Stem Cell Based Exosomes: Are They Effective in Disease or Health?

  2021cites this paper
• PDL1‐positive exosomes suppress antitumor immunity by inducing tumor‐specific CD8+ T cell exhaustion during metastasis

  2021cites this paper
• The Role of Extracellular Vesicles in the Development of a Cancer Stem Cell Microenvironment Niche and Potential Therapeutic Targets: A Systematic Review

  2021cites this paper
• Exosomes: Small EVs with Large Immunomodulatory Effect in Glioblastoma

  2021cites this paper
• What Is the Role of HLA-I on Cancer Derived Extracellular Vesicles? Defining the Challenges in Characterisation and Potential Uses of This Ligandome

  2021cites this paper
• The Interplay of Exosomes and NK Cells in Cancer Biology

  2021cites this paper
• Acidic and Hypoxic Microenvironment in Melanoma: Impact of Tumour Exosomes on Disease Progression

  2021cites this paper
• The interweaving relationship between extracellular vesicles and T cells in cancer.

  2021cites this paper
• Natural Killer Cell Phenotype and Functionality Affected by Exposure to Extracellular Survivin and Lymphoma-Derived Exosomes

  2021cites this paper
• Tumor-Associated Exosomes: A Potential Therapeutic Target for Restoring Anti-Tumor T Cell Responses in Human Tumor Microenvironments

  2021cites this paper
• The Role of Exosomes and Their Applications in Cancer

  2021cites this paper
• Fine-Tuning the Tumour Microenvironment: Current Perspectives on the Mechanisms of Tumour Immunosuppression

  2021cites this paper
• Extracellular Vesicles from Mesenchymal Stromal Cells for the Treatment of Inflammation-Related Conditions

  2021cites this paper
• Unlocking the Power of Exosomes for Crossing Biological Barriers in Drug Delivery

  2021cites this paper
• Extracellular Vesicles: Emerging Modulators of Cancer Drug Resistance

  2021cites this paper
• Extracellular Vesicles in Lung Cancer Metastasis and Their Clinical Applications

  2021cites this paper
• The effects of tumor‐derived exosomes on T‐cell function and efficacy of cancer immunotherapy

  2021cites this paper
• Nanoplasmonic Sensor Approaches for Sensitive Detection of Disease-Associated Exosomes.

  2021cites this paper
• Multiple Myeloma Cell-Derived Exosomes: Implications on Tumorigenesis, Diagnosis, Prognosis and Therapeutic Strategies

  2021cites this paper
• Emerging role of tumor-derived extracellular vesicles in T cell suppression and dysfunction in the tumor microenvironment

  2021cites this paper
• New Advances in the Research of Resistance to Neoadjuvant Chemotherapy in Breast Cancer

  2021cites this paper
• Emerging role of tumor microenvironment derived exosomes in therapeutic resistance and metastasis through epithelial-to-mesenchymal transition.

  2021cites this paper
• Exosomes as delivery tools in cancer therapy: Future perspectives

  2021cites this paper
• Investigating the Immune Function and Proteomic Profiles of Plasmal Exosomes in Lactobacillus Plantarum-treated Immunosuppressive Broilers

  2021cites this paper
• Oncolytic Virus Therapy Alters the Secretome of Targeted Glioblastoma Cells

  2021cites this paper